Search Results 241-250 of 17146 for egfr

1. A Study To Learn About The Medicine Ponsegromab In Adults With Cancer Of The Pancreas Which Has Spread And Caused Significant Body Weight Loss And Fatigue - Mayo Clinic

   Renal disease requiring dialysis or eGFR <30 mL/min/1.73m2. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 11 ...

2. Chronic Kidney Disease Clinical Trials - Mayo Clinic Research

   ... [eGFR] <30 or on dialysis). This is a multicenter randomized controlled trial with a target randomization of ~1000 patients with advanced CKD and at least ...

3. Presentations and Publications - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

   Posters · Bystander effects of EGFR-targeting 40H3 antibody-drug conjugates in glioblastoma with heterogeneous EGFR expression (PDF) · 2023 AACR annual meeting, ...

4. Publications - Rachael A. Vaubel, M.D., Ph.D. - Mayo Clinic

   EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype? J Neuropathol Exp Neurol. 2025 Nov 1; 84 (11):1059-1062. View PubMed ...

5. Another critical reason to prevent and control diabetes: It is a top cause of chronic kidney disease - Mayo Clinic News Network

   Discover the critical link between diabetes and chronic kidney disease. Learn more from a Mayo Clinic expert on the link.

6. Publications - Yanyan Lou, M.D., Ph.D. - Mayo Clinic

   Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer. ... Germline Mutation of T790M and Dual/Multiple EGFR Mutations in ...

7. A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers - Mayo Clinic

   estimated Glomerular Filtration Rate (eGFR) ≥ 60 ml/min by Modification of Diet in Renal Disease criteria;; Alanine aminotransferase (ALT) and aspartate ...

8. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

   ... EGFR mutations targeted by third generation TKIs [e.g., T790M for osimertinib]). NSCLC patients after failure of up to 4 prior treatment regimens containing ...

9. A Study to Evaluate Genetic Testing in Guiding Treatment for Patients with Brain Metastases - Mayo Clinic

   For lung cancer, EGFR mutant patients must have failed EGFR therapies; For HER2-positive breast cancer patients, patients must have received at least one ...

10. SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2; Admitted to or expected to be admitted to an intensive care unit for medical reasons (not ...